SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000078003-19-000070
Filing Date
2019-09-12
Accepted
2019-09-12 16:55:55
Documents
1
Period of Report
2019-09-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 7322
  Complete submission text file 0000078003-19-000070.txt   9526
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39044 | Film No.: 191090866
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Issuer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 2127332323
Pfizer Ventures (US) LLC (Reporting) CIK: 0001776087 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39044 | Film No.: 191090865